Amanda L Fyles - FDA Investigator Report

Overview Statistics

12
Total Inspections
12
Total 483s Issued
1
Warning Letters Issued

Inspection Details

Longest Inspection: 71 days
Shortest Inspection: 3 days
Average Length: 19.5 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Amanda L Fyles's Recent Inspections

DateCompanyCityCountryFEI Number483
2019-05-31IDT Australia Ltd.BoroniaAustralia3000219354
2019-05-02Tanvex BioPharma USA, IncSan DiegoUnited States3013021112
2019-04-11Pyramid Laboratories, Inc.Costa MesaUnited States1000160734
2019-01-18Teva Parenteral Medicines IncIrvineUnited States2027158
2018-08-09University of Southern CA, DBA USC Molecular Imaging CenterLos AngelesUnited States3012058126
2018-07-27Bend Research IncBendUnited States1000656789
2018-06-29B. Braun Medical IncIrvineUnited States2021236
2018-06-07Shadow Holdings DBA Bocchi LabsSanta ClaritaUnited States1000125317
2018-04-12Insys Development Company, Inc.ChandlerUnited States3006646520
2017-05-26Alliance Medical Products, Inc. DBA Siegfried CompanyIrvineUnited States2027189

Sign Up to get the complete report.

Download 483s and EIRs for Amanda L Fyles

Amanda L Fyles - Co-Inspectors

Amanda L Fyles's Active Locations

  • United States
  • Australia

Amanda L Fyles's Year-wise Inspection Count

  • 2016:1 inspections
  • 2017:2 inspections
  • 2018:5 inspections
  • 2019:4 inspections
Last Updated: 2025-05-14 06:11:22